🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 7

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 7 of 9
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Feb 15, 2026 at 9:33 PM#31

Following on from sarah_TO — and this may be the naive question:

How long did you give it before you decided it was working?

12 10Dr.LipidDallas, alex_tucson, kevin_tulsa and 9 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Feb 22, 2026 at 8:39 PM#32
NurseAsh_DET said:
Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

13 11julia.endo, JessicaM_2024, TomFromTexas and 10 others
Reply Quote Save Share Report
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Mar 1, 2026 at 7:41 PM#33
NurseAsh_DET said:
Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

14 12laura_annarbor, JenMemphis, pat_auckland and 11 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Mar 8, 2026 at 6:39 PM#34
NurseAsh_DET said:
Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

This answered a question I did not know how to ask. Printing the relevant bit and taking it with me.

15 13DataDave, Dr.GutHealth, amsterdam_pete and 12 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Mar 15, 2026 at 5:33 PM#35

From the other side of the consultation, briefly. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

16 14SandraNC_45, Dr.EndoIndy, tom_AK and 13 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register